Eric Distad

Mr. Distad comes to Cerebral Therapeutics with over 24 years’ experience in medical device and combination product clinical development. He has been responsible for the development and management of over 40 IDE studies from protocol development through final submission to regulatory authorities and focused on Class III devices and drug-device combination products in the therapeutic areas of movement disorders and epilepsy. Prior to joining Cerebral Therapeutics, Mr. Distad’s experience included Global Program Management at Medtronic in the Cardiac Rhythm Management and Neuromodulation Divisions, start-up and early commercial orthopedic companies, as well as leadership roles at two large Clinical Research Organizations within their Global Medical Device and Combination Product Divisions. In addition, Mr. Distad has served in advisory positions for Medical Technology Angel Funding groups, International Medical Device and Combination Product Regulatory Panels and Therapeutic Advisory Panels.